Inhibitory Effects of Trehalose on Malignant Melanoma Cell Growth: Implications for a Novel Topical Anticancer Agent on the Ocular Surface
Figure 3
Macroscopic findings for the subconjunctivally inoculated malignant melanoma cells from the F334/NJcl-rmu/rmu rats at 28 days after inoculation. Topical trehalose concentrations were 0% (a), 5% (b), and 10% (c). The tumor masses found in the trehalose instilled groups were macroscopically smaller than those observed in the control group for both the horizontal and vertical dimensions of the tumor.